The Randomized Controlled Clinical Trial of Kushen Injection
Status:
Unknown status
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
The randomized controlled multicenter clinical study of compound Kushen Injection to reduce
the radiotherapy related adverse reactions in lung cancer is a phase Ⅳ clinical trials，The
main purpose is to evaluate the effect of compound Kushen Injection in preventing and
reducing the radiotherapy related adverse reactions. The participants of the clinical trials
are patients with lung cancer who need thoracic radiotherapy. In clinical trials, one group
of participants is given compound Kushen Injection with chemoradiotherapy, while another
group is only given chemoradiotherapy. The period of trials is 18 months.